Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza H1N1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03743688
What this trial is testing

Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults

Who this might be right for
InfluenzaInfluenza, HumanVaccine Reaction+4 more
Vanderbilt University Medical Center 10
Not applicableStudy completedNCT00996853
What this trial is testing

Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom

Who this might be right for
Influenza
GlaxoSmithKline 9,206
Large-scale testing (Phase 3)Study completedNCT01031719
What this trial is testing

Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors

Who this might be right for
H1N1 Influenza VirusInvasive Solid Tumors
Chiltern Pesquisa Clinica Ltda 59
Testing effectiveness (Phase 2)Study completedNCT01078701
What this trial is testing

Dose Finding Study of Single Dose GHB11L1 in Healthy Adults

Who this might be right for
Influenza, Human
AVIR Green Hills Biotechnology AG 49
Large-scale testing (Phase 3)Study completedNCT01032395
What this trial is testing

Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus

Who this might be right for
H1N1 Influenza VirusChronic Pulmonary DiseaseChronic Heart Disease+1 more
Chiltern Pesquisa Clinica Ltda 342
Large-scale testing (Phase 3)Study completedNCT06385821
What this trial is testing

Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus

Who this might be right for
InfluenzaInfluenza AInfluenza, Human+8 more
NPO Petrovax 824
Post-approval studies (Phase 4)Study completedNCT01001026
What this trial is testing

Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Aboriginal Children and Adults

Who this might be right for
H1N1/2009 Influenza
David Scheifele 156
Testing effectiveness (Phase 2)Study completedNCT00992017
What this trial is testing

Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

Who this might be right for
HIV InfectionsH1N1 Influenza Virus
National Institute of Allergy and Infectious Diseases (NIAID) 130
Not applicableUnknownNCT01046227
What this trial is testing

Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology Patients

Who this might be right for
Serology AnalysisNovel H1N1 Influenza VaccinationPediatric Haemato-oncology Patients
National Taiwan University Hospital 50
Testing effectiveness (Phase 2)Study completedNCT02921997
What this trial is testing

H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses

Who this might be right for
Avian InfluenzaH1N1 InfluenzaInfluenza
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)Study completedNCT00963157
What this trial is testing

Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 789
Not applicableStudy completedNCT01003288
What this trial is testing

Studies of Pandemic Influenza (H1N1) 2009 Vaccine in Bergen

Who this might be right for
Healthy
University of Bergen 255
Not applicableStudy completedNCT01046734
What this trial is testing

Virus Shedding and Environmental Deposition of a Novel Influenza Virus

Who this might be right for
Novel (H1N1) Influenza
University of Nottingham 105
Not applicableStudy completedNCT01191853
What this trial is testing

Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines

Who this might be right for
Healthy VolunteersInfluenza
National Heart, Lung, and Blood Institute (NHLBI) 203
Large-scale testing (Phase 3)Study completedNCT00979602
What this trial is testing

Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older

Who this might be right for
Influenza
GlaxoSmithKline 4,048
Post-approval studies (Phase 4)Study completedNCT01004653
What this trial is testing

A Clinical Trial of Split-virion Influenza A/H1N1 Vaccines

Who this might be right for
Influenza
Sinovac Biotech Co., Ltd 100
Large-scale testing (Phase 3)Study completedNCT00989287
What this trial is testing

Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults

Who this might be right for
Influenza
GlaxoSmithKline 131
Testing effectiveness (Phase 2)WithdrawnNCT01037634
What this trial is testing

Safety and Efficacy of Oseltamivir in Children Younger Than One Year of Age

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)WithdrawnNCT02950688
What this trial is testing

Safety and Effectiveness of a Seasonal Live Attenuated Influenza Vaccine in a Human Challenge Model of Infection With Wild-type (wt) Influenza A/California/2009 (H1N1)-Like Virus

Who this might be right for
Influenza, Human
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT01218685
What this trial is testing

Evaluation of Pandemic Influenza A (H1N1) Vaccine in Chronic and or Immunocompromised Patients, Elderly and Pregnants

Who this might be right for
Immunocompromised PatientsSafety of Pandemic Influenza A (H1N1)VaccineImmunogenicity of Pandemic Influenza A (H1N1)Vaccine
Butantan Institute 1,152
Next Page